Your new post is loading...
Open dialogue and transparency in medicines pricing are imperative to ensure fair pricing for consumers, continued access to new medicines and the sustainability of the European healthcare systems. This was the message conveyed by the Deputy Prime Minister and Minister for Health Chris Fearne during meetings held in Brussels with representatives of the pharmaceutical industries and European Consumer Organisations.
